Claim joins a growing number of Ozempic Lawsuits being pursued by users, alleging that the drug maker failed to adequately disclose the severity of gastrointestinal side effects and long-term problems users may experience.
New MDL Judge has set a status conference for June 10, at which time she will meet with parties involved in Ozempic lawsuits for the first time.
An Ozempic lawsuits "Science Day" scheduled for next month has been cancelled, pending reassignment of the MDL to a new judge.
Federal health officials encourage anyone using the Tandem t:connect system to carefully monitor the battery levels to prevent unexpected pump failures, which could stop insulin delivery.
Research questions the supposed heart benefits of Jardiance, while other diabetes drugs are under fire for concerns over stomach paralysis risks.
Ahead of the Science Day, Judge Pratter has appointed 24 plaintiffs attorneys to serve in various leadership positions during the MDL proceedings
There was little difference in thyroid cancer rates among Ozempic and Mounjaro users, compared to those who took Januvia, Onglyza and similar diabetes medications.
The lead lawyers in the Ozempic MDL may choose up to 25 additional attorneys to serve on the Plaintiffs' Committee, who will take certain actions during pretrial proceedings that benefit plaintiffs in all GLP-1 lawsuits
Lawyers indicate that that questions about whether the GLP-1 RA medication label warnings adequately disclose the risk of gastroparesis and other severe injuries will play a large role in the growing litigation.
Eli Lilly failed to warn users that side effects of Trulicity may cause gastroparesis, despite numerous studies, case reports and medical literature indicating that users may experience severe stomach paralysis.
